Spyridon Papapetropoulos

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. doi request reprint Patient diaries as a clinical endpoint in Parkinson's disease clinical trials
    Spyridon Spyros Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, FL, USA
    CNS Neurosci Ther 18:380-7. 2012
  2. doi request reprint Objective tremor registration during DBS surgery for essential tremor
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, United States
    Clin Neurol Neurosurg 111:376-9. 2009
  3. ncbi request reprint Optimizing human post-mortem brain tissue gene expression profiling in Parkinson's disease and other neurodegenerative disorders: from target "fishing" to translational breakthroughs
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
    J Neurosci Res 85:3013-24. 2007
  4. ncbi request reprint Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Room 4004, 1501 NW 9th Avenue, Miami, FL 33136, USA
    Neurochem Int 50:998-1003. 2007
  5. ncbi request reprint Primary craniocervical dystonia presenting as a respiratory emergency
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, 1501 NW 9th Avenue NPF, Room 4004, Miami, FL 33136, USA
    Neurology 68:388-9. 2007
  6. ncbi request reprint Phenotypic associations of tau and ApoE in Parkinson's disease
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, United States
    Neurosci Lett 414:141-4. 2007
  7. pmc Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL, USA
    Head Face Med 2:47. 2006
  8. ncbi request reprint Motor fluctuations and dyskinesias in advanced/end stage Parkinson's disease: a study from a population of brain donors
    S Papapetropoulos
    Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA
    J Neural Transm 114:341-5. 2007
  9. ncbi request reprint Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Clin Neuropharmacol 29:364-7. 2006
  10. ncbi request reprint A progressive, fatal dystonia-Parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, and Massachusetts General Hospital, Boston, USA
    Mov Disord 22:1664-6. 2007

Research Grants

  1. The Basis of Psychotic Symptoms in Parkinson's Disease
    Spyridon Papapetropoulos; Fiscal Year: 2007

Detail Information

Publications52

  1. doi request reprint Patient diaries as a clinical endpoint in Parkinson's disease clinical trials
    Spyridon Spyros Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, FL, USA
    CNS Neurosci Ther 18:380-7. 2012
    ..Electronic diaries may help reducing some of these problems but may be associated with other challenges in large, multicenter studies...
  2. doi request reprint Objective tremor registration during DBS surgery for essential tremor
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, United States
    Clin Neurol Neurosurg 111:376-9. 2009
    ..Simple electronic tremor registration methods during DBS of the Vim nucleus of the thalamus may supplement the existing methodology that is solely based on subjective measures derived from clinical observations...
  3. ncbi request reprint Optimizing human post-mortem brain tissue gene expression profiling in Parkinson's disease and other neurodegenerative disorders: from target "fishing" to translational breakthroughs
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
    J Neurosci Res 85:3013-24. 2007
    ..In this Review, we discuss the advantages and limitations of this technology in simple terms and identify the key variables that influence/limit gene expression profiling-derived translational breakthroughs in neurodegenerative diseases...
  4. ncbi request reprint Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Room 4004, 1501 NW 9th Avenue, Miami, FL 33136, USA
    Neurochem Int 50:998-1003. 2007
    ..Due to the wide geographical distribution of cyanobacteria and the possible implications of BMAA neurotoxic properties in public health more research towards this direction is warranted...
  5. ncbi request reprint Primary craniocervical dystonia presenting as a respiratory emergency
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, 1501 NW 9th Avenue NPF, Room 4004, Miami, FL 33136, USA
    Neurology 68:388-9. 2007
  6. ncbi request reprint Phenotypic associations of tau and ApoE in Parkinson's disease
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, United States
    Neurosci Lett 414:141-4. 2007
    ..Better determination of subsets of PD patients based upon the presence of specific phenotypic features may improve the accuracy of association studies...
  7. pmc Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL, USA
    Head Face Med 2:47. 2006
    ..We present here the clinical characteristics and treatment variables of a series of patients that developed an OMD-associated eating dysfunction...
  8. ncbi request reprint Motor fluctuations and dyskinesias in advanced/end stage Parkinson's disease: a study from a population of brain donors
    S Papapetropoulos
    Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA
    J Neural Transm 114:341-5. 2007
    ..Although advanced disease and L-dopa administration are closely tied to their development, other mechanisms involving synaptic aging, altered neuronal plasticity and post-synaptic degeneration may be involved...
  9. ncbi request reprint Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Clin Neuropharmacol 29:364-7. 2006
    ..One patient declined botulinum toxin injections and responded moderately when treated with trihexyphenidyl...
  10. ncbi request reprint A progressive, fatal dystonia-Parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, and Massachusetts General Hospital, Boston, USA
    Mov Disord 22:1664-6. 2007
    ..Physician awareness of this rare syndrome may lead to its better characterization and management...
  11. ncbi request reprint Retrocollis: classification, clinical phenotype, treatment outcomes and risk factors
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Eur Neurol 59:71-5. 2008
    ..7%). Of patients injected with botulinum toxin type A, 24.5% reported excellent, 32.1% moderate, 16.9% mild and 24.5% no response to injections. Oral antidystonic medications had limited contribution to symptom relief...
  12. ncbi request reprint Painful limbs/moving extremities
    S Papapetropoulos
    Division of Movement Disorders, Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    Acta Neurol Scand 117:224-30. 2008
    ..Future research in PLME should include prospective electrophysiological and functional imaging studies as well as clinical trials with botulinum toxin injections and oral pharmacological agents...
  13. ncbi request reprint A prospective study of familial versus sporadic Parkinson's disease
    Spiridon Papapetropoulos
    Department of Neurology, Regional University Hospital of Patras, Patras, Greece
    Neurodegener Dis 4:424-7. 2007
    ..Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Most cases are sporadic but about 10-15% of patients have a positive family history of PD...
  14. ncbi request reprint Case of pediatric acquired chronic hepatocerebral degeneration
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA
    Pediatr Neurol 38:67-70. 2008
    ..The pediatric phenotype of acquired chronic hepatocerebral degeneration is presented, and the differential diagnosis in regard to Wilson's disease and management alternatives are discussed...
  15. doi request reprint Objective monitoring of tremor and bradykinesia during DBS surgery for Parkinson disease
    S Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, 1120 NW 14th Street, Room 1349, Miami, FL 33136, USA
    Neurology 70:1244-9. 2008
    ..We conducted a pilot study to evaluate short-term intraoperative outcomes of unilateral macrostimulation of the STN-DBS in PD patients using a neuromotor symptom registration device (CATSYS 2000 System)...
  16. doi request reprint Giant arteriovenous malformation presenting as pediatric task-specific dystonia
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, 1501 NW 9th Avenue NPF, Miami, FL 33136, USA
    Neurology 70:1294. 2008
  17. pmc A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease
    Spiridon Papapetropoulos
    Divisions of Movement Disorders Department of Neurology, University of Miami, Miller School of Medicine Miami, FL, USA
    BMC Neurol 8:21. 2008
    ..To this end, we developed the University of Miami Parkinson's disease Hallucinations Questionnaire (UM-PDHQ) that allows comprehensive assessment of hallucinations in clinical or research settings...
  18. doi request reprint Is the G2019S LRRK2 mutation common in all southern European populations?
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, USA
    J Clin Neurosci 15:1027-30. 2008
    ..Accurate estimations of the frequency and penetrance of different LRRK2 mutations are essential for correct and cost-efficient use of genetic testing and proper genetic counseling of patients with Parkinson's disease...
  19. ncbi request reprint Insular pathology in Parkinson's disease patients with orthostatic hypotension
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Room 4004, 1501 NW 9th Avenue, Miami, FL 33136, USA
    Parkinsonism Relat Disord 13:308-11. 2007
    ..Our results suggest an association between the severity of PD-related neuropathology in the insular cortex and OH. Further research into the subject is warranted...
  20. ncbi request reprint Regional alpha-synuclein aggregation, dopaminergic dysregulation, and the development of drug-related visual hallucinations in Parkinson's disease
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Rm 4004, 1501 NW 9th Ave, FL 33136, USA
    J Neuropsychiatry Clin Neurosci 18:149-57. 2006
    ....
  21. ncbi request reprint Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami FL, 33136, USA
    J Neuropsychiatry Clin Neurosci 18:113-6. 2006
    ..Findings suggest that positive family history for dementia is associated with DLB with a yet unknown mechanism...
  22. ncbi request reprint Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
    S Papapetropoulos
    Department of Neurology, School of Medicine, University of Miami, Miami, FL, USA
    Acta Neurol Scand 111:353-9. 2005
    ..With this study we aim to determine the influence of AD pathology on the clinical phenotype of PD...
  23. ncbi request reprint Natural history of progressive supranuclear palsy: a clinicopathologic study from a population of brain donors
    Spiridon Papapetropoulos
    Department of Neurology, School of Medicine, University of Miami, Miami, FL 33136, USA
    Eur Neurol 54:1-9. 2005
    ..Our results further demonstrate and expand the varied clinical picture of PSP. Furthermore, we report associations between older age at onset, early dementia, early falls and smoking with shorter PSP duration...
  24. ncbi request reprint Anterocollis: clinical features and treatment options
    Spiridon Papapetropoulos
    Department of Neurology, Division of Movement Disorders, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Med Sci Monit 14:CR427-30. 2008
    ..It has been mainly described in the context of parkinsonian movement disorders including Parkinson's disease and multiple system atrophy...
  25. ncbi request reprint Psychotic symptoms in Parkinson's disease. From description to etiology
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, School of Medicine, Room 4004, 1501 NW 9th Avenue, Miami FL 33136, USA
    J Neurol 252:753-64. 2005
    ....
  26. ncbi request reprint Factors associated with drug-induced visual hallucinations in Parkinson's disease
    Spiridon Papapetropoulos
    Dept of Neurology, University of Miami, School of Medicine, Room 4004, 1501 NW 9th Avenue, Miami, FL 33136, USA
    J Neurol 252:1223-8. 2005
    ..The aim of this study was to identify possible risk factors and determine clinical characteristics associated with the development of visual hallucinations in PD...
  27. ncbi request reprint A case of L-dopa-responsive parkinsonian syndrome after low-dose oral methotrexate intake
    Spiridon Papapetropoulos
    Department of Neurology, Regional University Hospital, Patras, Greece
    Clin Neuropharmacol 27:95-8. 2004
  28. ncbi request reprint The effect of depression on motor function and disease severity of Parkinson's disease
    Spiridon Papapetropoulos
    Department of Neurology, Medical School of Patras, Greece Department of Neurology, University of Miami, School of Medicine, Room 4004, 1501 NW 9th Avenue, Miami, FL 33136, USA
    Clin Neurol Neurosurg 108:465-9. 2006
    ..Approximately 40% of patients with Parkinson's disease (PD) experience symptoms of depression. Our aim was to evaluate the effect of depression on disease severity, motor function and other phenotypic characteristics of PD...
  29. ncbi request reprint Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP)
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Parkinsonism Relat Disord 11:459-63. 2005
    ..Deaths that occurred during winter and spring months accounted for about 70% of deaths among PSP patients. The most common co-morbid condition in PSP was hypertension, present in 50% of cases...
  30. ncbi request reprint Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations
    Spiridon Papapetropoulos
    Department of Neurology, Miller School of Medicine, University of Miami, 1501 NW 9th Avenue NPF, Room 4004, Miami, FL 33136, USA
    Parkinsonism Relat Disord 12:253-6. 2006
    ..Although our results suggest significant extranigral involvement, the precise etiopathologic mechanisms responsible for the development of VH need further clarification...
  31. ncbi request reprint Melatonin MT1 and MT2 receptor expression in Parkinson's disease
    Nikhil Adi
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL, USA
    Med Sci Monit 16:BR61-7. 2010
    ..Although the role of melatonin, a potent endogenous antioxidant, has been highlighted in PD there is no data on the expression of melatonin receptors in affected CNS regions...
  32. doi request reprint Expression of Lewy body protein septin 4 in postmortem brain of Parkinson's disease and control subjects
    Lina Shehadeh
    Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
    Mov Disord 24:204-10. 2009
    ..Considering the heterogeneous etiology of sporadic PD and the variability of individual human samples, SEPT4 accumulation may be regarded as one of the common pathological changes in PD and should therefore be further explored...
  33. pmc β-N-methylamino-L-alanine induces neurological deficits and shortened life span in Drosophila
    Xianchong Zhou
    Department of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, Miami, Florida, USA
    Toxins (Basel) 2:2663-79. 2010
    ..Our studies indicate that BMAA exposure causes chronic neurotoxicity, and that Drosophila serves as a useful model in dissecting the pathogenesis of ALS/PDC...
  34. pmc Subthreshold depression in Parkinson's disease
    Daniel A Nation
    Department of Psychology, University of Miami, Coral Gables, FL, USA
    Int J Geriatr Psychiatry 24:937-43. 2009
    ..The current study sought to determine the prevalence of subthreshold depression (sD) and to further characterize the associated features in a sample of 111 nondemented patients with moderate to severe PD...
  35. pmc Objective quantification of neuromotor symptoms in Parkinson's disease: implementation of a portable, computerized measurement tool
    Spyridon Papapetropoulos
    Department of Neurology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Parkinsons Dis 2010:760196. 2010
    ..More work is warranted to establish CATSYS as a diagnostic/monitoring instrument in movement disorders using the proposed technical approaches...
  36. pmc Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset
    Andreas Plaitakis
    Department of Neurology, Medical School, University of Crete, Heraklion, Crete, Greece
    Eur J Hum Genet 18:336-41. 2010
    ..The lack of effect in female heterozygous PD patients could be related to a modification of the overactive variant enzyme by estrogens...
  37. doi request reprint Contemporary Encephalitis Lethargica: phenotype, laboratory findings and treatment outcomes
    Robert Lopez-Alberola
    Dept of Pediatrics, University of Miami, Miller School of Medicine, Miami 33136, USA
    J Neurol 256:396-404. 2009
    ..Against this background we conducted a study aiming to elucidate the clinical characteristics, describe laboratory/ neuroimaging findings (MRI, PET) and present treatment options and outcomes in sporadic EL...
  38. ncbi request reprint Dementia in Parkinson's disease: a post-mortem study in a population of brain donors
    S Papapetropoulos
    Department of Neurology University of Miami, School of Medicine, FL 33136, USA
    Int J Geriatr Psychiatry 20:418-22. 2005
    ..To identify factors associated with dementia in a cohort of Parkinson's disease (PD) brain donors and determine whether its presence may influence the clinical phenotype of the disease...
  39. ncbi request reprint Pontine/extrapontine myelinolysis occurring in the setting of an eating disorder
    C Singer
    Department of Neurology, University of Miami School of Medicine, 1501 NW 9 Ave, Miami, FL 33136, USA
    Neurology 64:2156-7. 2005
  40. pmc Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)
    Joseph Jankovic
    Baylor College of Medicine, Department of Neurology, Houston, TX, USA
    BMC Neurol 11:140. 2011
    ..Irvine, CA, USA). Methods and baseline demographics from an interim analysis are provided...
  41. doi request reprint BMAA neurotoxicity in Drosophila
    Xianchong Zhou
    Department of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, Miami, Florida, USA
    Amyotroph Lateral Scler 10:61-6. 2009
    ..We found that dietary intake of BMAA reduced the lifespan as well as the neurological functions of flies. Furthermore, we have developed an HPLC method to reliably detect both free and protein-bound BMAA in fly tissue extracts...
  42. ncbi request reprint A registry-based, case-control investigation of Parkinson's disease with and without cognitive impairment
    S Papapetropoulos
    Department of Neurology, Regional University Hospital of Patras, Rion, Patras, Greece
    Eur J Neurol 11:347-51. 2004
    ..PD patients should be routinely and carefully screened for dementia and caregivers should be aware of the effect of dementia on PD...
  43. ncbi request reprint Clinical characteristics of the alpha-synuclein mutation (G209A)-associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece
    S Papapetropoulos
    Department of Neurology and Biology, Medical School of Patras, Patras, Greece
    Eur J Neurol 10:281-6. 2003
    ..The alpha-synPD patients presented the illness at a younger age and also had lower prevalence of tremor when compared with the fPD patients...
  44. ncbi request reprint Comparison of motor fluctuations and L-dopa-induced dyskinesias in patients with familial and sporadic Parkinson's disease
    S Papapetropoulos
    Department of Neurology, Medical School of Patras, Patras, Greece
    Eur J Neurol 11:115-9. 2004
    ..FPD may be associated with a higher prevalence and earlier onset of motor complications during the initial stages of the disease. Genetic factors may contribute to the specific characteristics of motor complications in fPD...
  45. pmc Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease
    S Papapetropoulos
    Department of Neurology, Medical School of Patras, Greece
    J Neurol Neurosurg Psychiatry 70:662-5. 2001
    ..The other symptoms and signs of the illness did not seem to differentiate the patients with alpha-synPD from those with sPD...
  46. ncbi request reprint The effect of vascular disease on late onset Parkinson's disease
    S Papapetropoulos
    Department of Neurology, Medical School of Patras, Rion, Greece
    Eur J Neurol 11:231-5. 2004
    ..In clinical grounds, these findings can be proved significant since early and aggressive prevention of vascular disease and treatment of vascular risk may contribute in controlling symptom severity in PD...
  47. ncbi request reprint Urinary and erectile dysfunction in multiple system atrophy (MSA)
    A G Papatsoris
    Second Department of Urology, School of Medicine, University of Athens, Sismanoglio General Hospital, Athens, Greece
    Neurourol Urodyn 27:22-7. 2008
    ..In this review, we present the phenotypic range and therapeutic approaches for common storage and voiding urological symptoms and ED, in patients with MSA...
  48. ncbi request reprint Headache characteristics and brain metastases prediction in cancer patients
    A A Argyriou
    Department of Medicine, Division of Clinical Oncology, General Hospital of Kos Island, and Neurology Department, Regional University Hospital of Patras, Greece
    Eur J Cancer Care (Engl) 15:90-5. 2006
    ..1; 95% CI. 2.2-120.7). In conclusion, all cancer patients who manifest the above independent clinical predictors should be highly suspected for appearance of brain metastases and therefore should be thoroughly investigated...
  49. ncbi request reprint Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial
    A A Argyriou
    Neurology Department, University of Patras, Medical School, PO Box 1045, Rion, Patras, Greece
    Neurology 64:26-31. 2005
    ..The authors conducted a pilot, randomized, open label with blind assessment, controlled trial to determine whether vitamin E supplementation has a neuroprotective effect in chemotherapy-induced peripheral nerve damage...
  50. doi request reprint Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease
    J Pablo
    Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    Acta Neurol Scand 120:216-25. 2009
    ..These observations warranted an independent study of possible BMAA exposures outside of the Guam ecosystem...
  51. ncbi request reprint Past tense formation and comprehension of passive sentences in Parkinson's disease: evidence from Greek
    Arhonto Terzi
    Department of Speech and Language Therapy, Technological Educational Institute of Patras, Greece
    Brain Lang 94:297-303. 2005
    ....
  52. doi request reprint A formula for the conversion of UPDRS-III scores to Hoehn and Yahr stage
    Blake K Scanlon
    Parkinsonism Relat Disord 14:379-80. 2008

Research Grants1

  1. The Basis of Psychotic Symptoms in Parkinson's Disease
    Spyridon Papapetropoulos; Fiscal Year: 2007
    ..Recent publications from our group, our preliminary results, the brain tissue availability and the multidisciplinary team assembled provide strong support for the feasibility of this project. ..